Application of LC–MS/MS Method for Determination of Dihydroartemisin in Human Plasma in a Pharmacokinetic Study

References

• Zhang D , YangL. Summary of dihydrotemisnin and its application for the treatment of lupus erythematosus (in Chinese). Chin. Sci. Bull.62, 2007–2012 (2017).
   Google Scholar
• Li WD , DongYJ, TuYY, LinZB. Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int. Immunopharmacol.6(8), 1243–1250 (2006).
   PubMedGoogle Scholar
• Huang X , XieZ, LiuFet al. Dihydroartemisinin inhibits activation of the Toll-like receptor 4 signaling pathway and production of type I interferon in spleen cells from lupus-prone MRL/lpr mice. Int. Immunopharmacol.22(1), 266–272 (2014).
   PubMed Web of Science ®Google Scholar
• Chen Xuerong , XuLimin, TuYouyou. Effect of dihydroartemisinin on lupus BXSB mice (in Chinese). [Chinese Journal of Dermatovenerology of Integrated Traditional and Western Medicine] 1, 19–20 (2002).
   Google Scholar
• Huang L , JayewardeneAL, LiX, MarzanF, LizakPS, AweekaFT. Development and validation of a high-performance liquid chromatography/tandem mass spectrometry method for the determination of artemether and its active metabolite dihydroartemisinin in human plasma. J. Pharm. Biomed. Anal.50(5), 959–965 (2009).
   PubMed Web of Science ®Google Scholar
• Lindegardh N , HanpithakpongW, KamanikomBet al. Quantification of dihydroartemisinin, artesunate and artemisinin in human blood: overcoming the technical challenge of protecting the peroxide bridge. Bioanalysis3(14), 1613–1624 (2011).
   PubMed Web of Science ®Google Scholar
• Rathod DM , PatelKR, MistriHN, JangidAG, ShrivastavPS, SanyalM. Application of an LC-MS/MS method for reliable determination of amodiaquine, N-desethylamodiaquine, artesunate and dihydroartemisinin in human plasma for a bioequivalence study in healthy Indian subjects. J. Pharm. Biomed. Anal.124, 67–78 (2016).
   PubMed Web of Science ®Google Scholar
• Souppart C , GauducheauN, SandrenanN, RichardF. Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.774(2), 195–203 (2002).
   PubMedGoogle Scholar
• Lindegardh N , HanpithakpongW, KamanikomBet al. Major pitfalls in the measurement of artemisinin derivatives in plasma in clinical studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.876(1), 54–60 (2008).
   PubMed Web of Science ®Google Scholar
• Geditz MC , HeinkeleG, AhmedAet al. LC-MS/MS method for the simultaneous quantification of artesunate and its metabolites dihydroartemisinin and dihydroartemisinin glucuronide in human plasma. Anal. Bioanal. Chem.406(17), 4299–4308 (2014).
   PubMedGoogle Scholar
• Hanpithakpong W , KamanikomB, DondorpAMet al. A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.876(1), 61–68 (2008).
   PubMed Web of Science ®Google Scholar
• Hilhorst MJ , HendriksG, DeVries R, HillewaertV, VerhaegeT, VanDe Merbel NC. A high-performance liquid chromatography-tandem mass spectrometry method for the determination of artemether and dihydroartemisinin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.965, 45–53 (2014).
   PubMed Web of Science ®Google Scholar
• Hong X , LiuCH, HuangXTet al. Pharmacokinetics of dihydroartemisinin in Artekin tablets for single and repeated dosing in Chinese healthy volunteers. Biopharm. Drug Dispos.29(4), 237–244 (2008).
   PubMedGoogle Scholar
• Souppart C , GauducheauN, SandrenanN, RichardF. Development and validation of a high-performance liquid chromatography-mass spectrometry assay for the determination of artemether and its metabolite dihydroartemisinin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.774(2), 195–203 (2002).
   PubMedGoogle Scholar
• Rajanikanth M , MadhusudananKP, GuptaRC. An HPLC-MS method for simultaneous estimation of alpha,beta-arteether and its metabolite dihydroartemisinin, in rat plasma for application to pharmacokinetic study. Biomed. Chromatogr.17(7), 440–446 (2003).
   PubMed Web of Science ®Google Scholar
• Lai CS , NairNK, MuniandyA, MansorSM, OlliaroPL, NavaratnamV. Validation of high performance liquid chromatography-electrochemical detection methods with simultaneous extraction procedure for the determination of artesunate, dihydroartemisinin, amodiaquine and desethylamodiaquine in human plasma for application in clinical pharmacological studies of artesunate-amodiaquine drug combination. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.877(5–6), 558–562 (2009).
   PubMed Web of Science ®Google Scholar
• Jessing KK , JuhlerRK, StrobelBW. Monitoring of artemisinin, dihydroartemisinin, and artemether in environmental matrices using high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). J. Agric. Food Chem.59(21), 11735–11743 (2011).
   PubMedGoogle Scholar
• Huang L , OlsonA, GingrichD, AweekaFT. Determination of artemether and dihydroartemisinin in human plasma with a new hydrogen peroxide stabilization method. Bioanalysis5(12), 1501–1506 (2013).
   PubMed Web of Science ®Google Scholar
• Hanpithakpong W , KamanikomB, DondorpAMet al. A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.876(1), 61–68 (2008).
   PubMed Web of Science ®Google Scholar
• Duthaler U , KeiserJ, HuwylerJ. Development and validation of a liquid chromatography and ion spray tandem mass spectrometry method for the quantification of artesunate, artemether and their major metabolites dihydroartemisinin and dihydroartemisinin-glucuronide in sheep plasma. J. Mass Spectrom.46(2), 172–181 (2011).
   PubMed Web of Science ®Google Scholar
• US FDA . Bioanalytical Method Validation Guidance for Industry. (2013). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM368107.pdf
   Google Scholar
• European Medicines Agency . Guideline on Bioanalytical Method Validation. (2011). http://www.ema.europa.eu/docs/enGB/documentlibrary/Scientificguideline/2011/08/WC500109686.pdf
   Google Scholar
• Chinese Food and Drug Administration . Technical Guidelines for the Pharmacokinetics Study of Chemical Drugs (2005). http://www.cde.org.cn/zdyz.do?method=largePage&id=8b461127bccfdd5e.pdf
   Google Scholar
• Jemal M , OuyangZ, XiaYQ. Systematic LC–MS/MS bioanalytical method development that incorporates plasma phospholipids risk avoidance, usage of incurred sample and well thought-out chromatography. Biomed. Chromatogr.24(1), 2–19 (2010).
   PubMed Web of Science ®Google Scholar